A cancer-pain case report raises concern about THC/CBD with opioids
Respiratory depression with concomitant use of opioids and cannabinoids: a case report.
AI Summary
This abstract-based summary describes a case report examining respiratory depression during combined opioid and cannabinoid use in a middle-aged patient with metastatic cancer and severe pain. After receiving hydromorphone and methadone, the patient took a 100 mg THC/CBD tincture and later became abnormally slow-breathing and unresponsive. The patient recovered after two administrations of naloxone.
The authors suggest the cannabinoid product may have contributed to acute opioid toxicity, possibly through inhibition of UGT2B7, an enzyme involved in opioid metabolism. This single case cannot establish that the tincture caused the event or determine how often such interactions occur; the proposed mechanism is not confirmed here. The abstract supports the authorsโ call for clinicians to ask about cannabinoid use and discuss potential risks when patients are also receiving high-dose opioids.
๐ก Key Findings
๐
Original Abstract
Related Research
Similar Studies
More THC research papers you might find interesting.
Small lab study finds cannabis affected simulated driving and confidence
A lab method measures 17 cannabinoids across five hemp product types
A single-center study finds varied care and no recurrence in follow-up
Explore More Research
Stay informed about the latest cannabis science.